Clinical Trial Update: Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

View source ↗

Summary

A post-marketing clinical follow-up study is ongoing to assess the efficacy and safety of the Occlutech PDA Occluder in patients with patent ductus arteriosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• Occlutech PDA Occluder

Snippet

Sponsor: Occlutech International AB | Conditions: Patent Ductus Arteriosus | Status: RECRUITING